RODNEY MARKIN
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DAVID COHEN, MARK P. COLONNESE, JEFF COSSMAN, ILAN DANIELI, KATRINA FAHLIN, DOUG FISHER, BRETT FREVERT, BRETT L FREVERT, CARL IBERGER, PAUL KINNON, DOIT KOPPLER, DOIT L KOPPLER, DOIT KOPPLER II, DOIT L KOPPLER II, DOIT L. KOPPLER II, DOIT L. KOPPLER, II, MICHAEL LUTHER, MICHAEL A. LUTHER, RODNEY S MARKIN, RODNEY S. MARKIN, ROBERT PATZIG, ROBERT M PATZIG, ROBERT M. PATZIG, SAMUEL RICCITELLI, SAMUEL D. RICCITELLI, CHAD RICHARDS, CHAD M RICHARDS, CHAD M. RICHARDS, LEON F. RICHARDS, MARK RIMER, ANTONIUS SCHUH, ANTONIUS P SCHUH, ANTONIUS P. SCHUH, MYA THOMAE, JOHN D. THOMPSON, CRAIG TUTTLE, CRAIG J TUTTLE, CRAIG J. TUTTLE
DIRECTOR
DIRECTOR
DIRECTOR
THOMAS ADAMS, THOMAS H. ADAMS, THOMAS ADAMS, PH.D., JAMES ARMITAGE, JAMES O. ARMITAGE, PAUL BILLINGS, JOHN BRANCACCIO, JOHN P. BRANCACCIO, GABRIELE CERRONE, ATHENA COUNTOURIOTIS, MARK ERLANDER, MARK ERLANDER, PH.D., GARY JACOB, GARY S. JACOB, GARY JACOB, PH.D., BRIGITTE LINDSAY, RODNEY S. MARKIN, GARY W. PACE, GARY PACE, PH.D., DAVID ROBBINS, ANTONIUS SCHUH, STANLEY TENNANT, WILLIAM WELCH, LALE WHITE, STEVE ZANIBOBI, STEVE ZANIBONI
DIRECTOR
DIRECTOR
THOMAS ADAMS, THOMAS H. ADAMS, THOMAS ADAMS, PH.D., JAMES ARMITAGE, JAMES O. ARMITAGE, PAUL BILLINGS, JOHN BRANCACCIO, JOHN P. BRANCACCIO, GABRIELE CERRONE, ATHENA COUNTOURIOTIS, MARK ERLANDER, MARK ERLANDER, PH.D., GARY JACOB, GARY S. JACOB, GARY JACOB, PH.D., BRIGITTE LINDSAY, RODNEY S. MARKIN, GARY W. PACE, GARY PACE, PH.D., DAVID ROBBINS, ANTONIUS SCHUH, STANLEY TENNANT, WILLIAM WELCH, LALE WHITE, STEVE ZANIBOBI, STEVE ZANIBONI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-05-12
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2017-07-19
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2012-02-02
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2010-12-29

